New Year's Summiteers

Photograph courtesy of Pamela Wolfe Crimson hikers (from left) Anne Walston ’67, Éva Borsody Das ’63, and Ken Moller...

Photograph courtesy of Pamela Wolfe

Crimson hikers (from left) Anne Walston ’67, Éva Borsody Das ’63, and Ken Moller ’69 spent early 2008 in Tanzania, climbing Mount Kilimanjaro, Africa’s tallest peak, in an international group sponsored by the Appalachian Mountain Club. To combat altitude sickness, the trekkers took six days to ascend; they needed only a day and a half to return to base camp. They spent about 20 minutes on the summit. “I don’t remember a lot of it,” Das told her Massachusetts hometown paper, the Hull Times. “Your brain cells are dying. I don’t remember the wind or the cold.” She’d already gone climbing again, in the Catskills.

Related topics

You might also like

A new book explores the Harvard-trained architect’s vision and impact, from Ground Zero to the Smithsonian.

The play Spare Parts is a contemporary fable about the quest to live forever.

Plus, veteran higher education leader Thomas Ehrlich reflects on university curricula for his 70th reunion

Most popular

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

The University has pushed the adoption of AI into teaching and operations, but faculty resistance is growing louder.

Harvard art historian Jennifer Roberts teaches the value of immersive attention

Teaching students the value of deceleration and immersive attention

Explore More From Current Issue

A woman with long, wavy hair wearing a white suit, seated in a bright, modern room.

The Harvard graduate’s roundtable talk show touches on hot button issues from religion to sex. 

A man in a suit speaks at a podium.

David Battat promotes alumni engagement.

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.